Cargando…
PAIP1 is a novel oncogene in human hepatocellular carcinoma
BACKGROUND: Poly(A)-binding protein interacting protein 1 (PAIP1) is a translational initiation regulatory factor that has been reported as oncogene in multiple malignant diseases. However, its role in hepatocellular carcinoma (HCC) and the potential mechanisms have not been explored. METHODS: PAIP1...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9702235/ https://www.ncbi.nlm.nih.gov/pubmed/36436074 http://dx.doi.org/10.1007/s12672-022-00530-0 |
_version_ | 1784839660273401856 |
---|---|
author | Zhang, Nuobei Chen, Xin |
author_facet | Zhang, Nuobei Chen, Xin |
author_sort | Zhang, Nuobei |
collection | PubMed |
description | BACKGROUND: Poly(A)-binding protein interacting protein 1 (PAIP1) is a translational initiation regulatory factor that has been reported as oncogene in multiple malignant diseases. However, its role in hepatocellular carcinoma (HCC) and the potential mechanisms have not been explored. METHODS: PAIP1 expression level in HCC cell lines were detected by real-time quantitative PCR and western blotting. The proliferation and colony formation of HCC cell lines were detected by MTT and colony formation assay. The apoptosis and cell cycle were detected by flow cytometry. The volume and growth rate of the xenograft tumors were observed. The potential mechanism of PAIP1 was analyzed by miRNA Microarray Analysis and TargetScan analysis. RESULTS: PAIP1 is significantly upregulated in HCC cell lines. PAIP1 knockdown dramatically inhibits cell proliferation and colony formation, induces apoptosis and alters the cell cycle distribution by increasing the G2/M cell percentage. Moreover, PAIP1 knockdown significantly reduces tumorigenesis in a murine transplantation model. Bioinformatics and immunoblotting analysis reveal that PAIP1 knockdown dysregulates cyclin D pathway-related proteins. CONCLUSION: PAIP1 plays an oncogenic role in hepatocellular carcinoma. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s12672-022-00530-0. |
format | Online Article Text |
id | pubmed-9702235 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-97022352022-11-29 PAIP1 is a novel oncogene in human hepatocellular carcinoma Zhang, Nuobei Chen, Xin Discov Oncol Research BACKGROUND: Poly(A)-binding protein interacting protein 1 (PAIP1) is a translational initiation regulatory factor that has been reported as oncogene in multiple malignant diseases. However, its role in hepatocellular carcinoma (HCC) and the potential mechanisms have not been explored. METHODS: PAIP1 expression level in HCC cell lines were detected by real-time quantitative PCR and western blotting. The proliferation and colony formation of HCC cell lines were detected by MTT and colony formation assay. The apoptosis and cell cycle were detected by flow cytometry. The volume and growth rate of the xenograft tumors were observed. The potential mechanism of PAIP1 was analyzed by miRNA Microarray Analysis and TargetScan analysis. RESULTS: PAIP1 is significantly upregulated in HCC cell lines. PAIP1 knockdown dramatically inhibits cell proliferation and colony formation, induces apoptosis and alters the cell cycle distribution by increasing the G2/M cell percentage. Moreover, PAIP1 knockdown significantly reduces tumorigenesis in a murine transplantation model. Bioinformatics and immunoblotting analysis reveal that PAIP1 knockdown dysregulates cyclin D pathway-related proteins. CONCLUSION: PAIP1 plays an oncogenic role in hepatocellular carcinoma. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s12672-022-00530-0. Springer US 2022-11-27 /pmc/articles/PMC9702235/ /pubmed/36436074 http://dx.doi.org/10.1007/s12672-022-00530-0 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Research Zhang, Nuobei Chen, Xin PAIP1 is a novel oncogene in human hepatocellular carcinoma |
title | PAIP1 is a novel oncogene in human hepatocellular carcinoma |
title_full | PAIP1 is a novel oncogene in human hepatocellular carcinoma |
title_fullStr | PAIP1 is a novel oncogene in human hepatocellular carcinoma |
title_full_unstemmed | PAIP1 is a novel oncogene in human hepatocellular carcinoma |
title_short | PAIP1 is a novel oncogene in human hepatocellular carcinoma |
title_sort | paip1 is a novel oncogene in human hepatocellular carcinoma |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9702235/ https://www.ncbi.nlm.nih.gov/pubmed/36436074 http://dx.doi.org/10.1007/s12672-022-00530-0 |
work_keys_str_mv | AT zhangnuobei paip1isanoveloncogeneinhumanhepatocellularcarcinoma AT chenxin paip1isanoveloncogeneinhumanhepatocellularcarcinoma |